Nuclear pore complex dysfunction drives TDP-43 pathology in ALS
- PMID: 40819564
- PMCID: PMC12390953
- DOI: 10.1016/j.redox.2025.103824
Nuclear pore complex dysfunction drives TDP-43 pathology in ALS
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron degeneration and pathological aggregation of TDP-43. While protein misfolding and impaired autophagy are established features, accumulating evidence highlights the nuclear pore complex (NPC)as a vulnerable, redox-sensitive hub in ALS pathogenesis. Here, we show that selective loss of NPC components, particularly the scaffold proteins NUP107 and NUP93, and FG-repeat-containing components-is a consistent finding across ALS postmortem spinal cord, SOD1^G93A and TDP-43 mutant mouse models, and human cell systems.CRISPR-mediated depletion of NUP107 in human cells triggers hallmark features of ALS pathology, including cytoplasmic TDP-43 mislocalization, increased phosphorylation, and autophagy dysfunction. Conversely, TDP-43 knockdown perturbs NPC composition, suggesting a reciprocal regulatory loop. Crucially, we demonstrate that oxidative stress exacerbated NPC subunit mislocalization and enhanced TDP-43 aggregation. Using oxime blotting and DNPH assays, we show that FG-repeat subunits of NPC were direct targets of redox-driven carbonylation, indicating that oxidative modifications compromise NPC integrity thuspotentially affecting nucleocytoplasmic transport. Our findings established NPC dysfunction as a redox-sensitive driver of TDP-43 pathology in ALS and highlight nucleocytoplasmic transport as a promising therapeutic axis. The susceptibility of long-lived NPC proteins to oxidative damage provides a mechanistic link between redox stress, proteostasis collapse, and neurodegeneration.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Coyne A.N., Baskerville V., Zaepfel B.L., Dickson D.W., Rigo F., Bennett F., Lusk C.P., Rothstein J.D. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 2021;13 doi: 10.1126/scitranslmed.abe1923. - DOI - PMC - PubMed
-
- Al-Azzam N., To J.H., Gautam V., Street L.A., Nguyen C.B., Naritomi J.T., Lam D.C., Madrigal A.A., Lee B., Jin W., Avina A., Mizrahi O., Mueller J.R., Ford W., Schiavon C.R., Rebollo E., Vu A.Q., Blue S.M., Madakamutil Y.L., Manor U., Rothstein J.D., Coyne A.N., Jovanovic M., Yeo G.W. Inhibition of RNA splicing triggers CHMP7 nuclear entry, impacting TDP-43 function and leading to the onset of ALS cellular phenotypes. Neuron. 2024;112:4033–4047.e8. doi: 10.1016/j.neuron.2024.10.007. - DOI - PMC - PubMed
-
- Okada K., Ito D., Morimoto S., Kato C., Oguma Y., Warita H., Suzuki N., Aoki M., Kuramoto J., Kobayashi R., Shinozaki M., Ikawa M., Nakahara J., Takahashi S., Nishimoto Y., Shibata S., Okano H. Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis. Brain. 2024;147:3933–3948. doi: 10.1093/brain/awae224. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
